OTC Markets OTCPK - Delayed Quote USD

Voyageur Pharmaceuticals Ltd. (VYYRF)

Compare
0.0020 0.0000 (0.00%)
As of December 16 at 3:00:00 PM EST. Market Open.
Currency in CAD All numbers in thousands
Breakdown
TTM
11/30/2023
11/30/2022
11/30/2021
11/30/2020
Operating Expense
1,477.9670
1,346.3790
1,751.9250
2,048.1910
982.3940
Operating Income
-1,477.9670
-1,346.3790
-1,751.9250
-2,048.1910
-982.3940
Net Non Operating Interest Income Expense
--
-4.4800
--
-3.2770
-18.6490
Other Income Expense
--
-48.6100
-1.9690
--
-138.3790
Pretax Income
-1,531.0570
-1,399.4690
-1,753.8940
-2,051.4680
-1,139.4220
Net Income Common Stockholders
-1,531.0580
-1,399.4690
-1,753.8940
-2,051.4670
-1,139.4220
Diluted NI Available to Com Stockholders
-1,531.0580
-1,399.4690
-1,753.8940
-2,051.4670
-1,139.4220
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.02
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.02
Basic Average Shares
135,951.7560
130,503.7730
107,826.0180
94,677.8870
70,527.8590
Diluted Average Shares
135,951.7560
130,503.7730
107,826.0180
94,677.8870
70,527.8590
Total Expenses
1,477.9670
1,346.3790
1,751.9250
2,048.1910
982.3940
Net Income from Continuing & Discontinued Operation
-1,531.0580
-1,399.4690
-1,753.8940
-2,051.4670
-1,139.4220
Normalized Income
-1,482.4480
-1,350.8590
-1,751.9250
-2,051.4670
-987.3180
Interest Expense
--
4.4800
--
3.2770
18.6490
Net Interest Income
--
-4.4800
--
-3.2770
-18.6490
EBIT
-1,526.5770
-1,394.9890
-1,753.8940
-2,048.1910
-1,120.7730
EBITDA
-1,524.8530
-1,392.8040
-1,744.6840
-2,039.9660
-1,119.2900
Reconciled Depreciation
1.7240
2.1850
9.2100
8.2250
1.4830
Net Income from Continuing Operation Net Minority Interest
-1,531.0580
-1,399.4690
-1,753.8940
-2,051.4670
-1,139.4220
Total Unusual Items Excluding Goodwill
-48.6100
-48.6100
-1.9690
--
-152.1040
Total Unusual Items
-48.6100
-48.6100
-1.9690
--
-152.1040
Normalized EBITDA
-1,476.2430
-1,344.1940
-1,742.7150
-2,039.9660
-967.1860
11/30/2020 - 10/19/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers